MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Adverse Drug Reaction Reporting

Drug Safety Update

November 2023: E-cigarette use or vaping: reminder to remain vigilant for suspected adverse reactions and safety concerns and report them to the Yellow Card scheme

January 2023: Electronic Prescribing and Medicines Administration Systems: report adverse incidents on a Yellow Card

 February 2020: Support Yellow Card: report suspected reactions in patients taking multiple medicines

Healthcare professionals have a professional responsibility to report suspected adverse drug reactions (ADRs)/side effects to the Medicines and Healthcare products Regulatory Agency (MHRA).

 What to report:

  • All suspected adverse drug reactions:
    • In children (even if a medicine has been used off-label)
    • In people aged over 65 years
    • For new medicines (drugs and vaccines ) - identified by the black triangle ▼ symbol
    • To biological medicines (such as blood products, antibodies and advanced therapies [such as gene and tissue therapy]) and vaccines
    • Associated with rare or delayed drug effects
    • Drug interactions
    • Congenital abnormalities
    • To complementary remedies, such as homeopathic and herbal products (licensed and unlicensed)
  • All serious suspected adverse drug reactions for established vaccines and medicines, including unlicensed medicines, herbal remedies, and medicines used off-label
  • Defective medicines (those that are not of an acceptable quality)
  • Fake or counterfeit medicines or medical devices
  • Adverse incident involving:
    • All medical devices available on the UK market
    • Nicotine-containing electronic cigarettes and refill containers (e-liquids)  

ADRs that occur as a result of a medication error should be reported through the Trust’s reporting system – DATIX.

How to report:

  • Through the Yellow Card Scheme using the electronic form at
  • By post. Paper copies are available:
    • By downloading and printing out a form from
    • By writing to FREEPOST YELLOW CARD (no other address details necessary)
    • By emailing
    • By calling the National Yellow Card Information Service on 0808 731 6789 (9am to 5pm Monday–Friday)
    • In the back cover of the British National Formulary (BNF) and British National Formulary for Children (BNFc)
  • Yellow Card Mobile App: download it from the Apple App Store or Google Play Store


Patients and their carers can also report suspected adverse drug reactions to the MHRA. Reports can be submitted directly to the MHRA through the Yellow Card Scheme using the electronic form at, by telephone on 0808 100 3352, or by downloading the Yellow Card form from

The Trust's Medicines Information centre can give information and advice on suspected ADRs. They can be contacted on extension 34217.